TNFRSF4 and neoplasm: In a seminal report by Sagiv-Barfi et al. [178], following intratumoral injections with CpG nucleotides and subsequent treatment with anti-Ox40, not only was a decrease in tumor volume at the injection observed, but untreated tumors at distant sites also demonstrated decreases.